Order Article Reprints

Núñez Y, Garcia-León A, Falgàs A, Serna N, Sánchez-García L, Garrido A, Sierra J, Gallardo A, Unzueta U, Vázquez E, et al. T22-PE24-H6 Nanotoxin Selectively Kills CXCR4-High Expressing AML Patient Cells In Vitro and Potently Blocks Dissemination In Vivo. Pharmaceutics. 2023; 15(3):727. https://doi.org/10.3390/pharmaceutics15030727

Núñez, Yáiza, Annabel Garcia-León, Aïda Falgàs, Naroa Serna, Laura Sánchez-García, Ana Garrido, Jorge Sierra, Alberto Gallardo, Ugutz Unzueta, Esther Vázquez, and et al. 2023. "T22-PE24-H6 Nanotoxin Selectively Kills CXCR4-High Expressing AML Patient Cells In Vitro and Potently Blocks Dissemination In Vivo" Pharmaceutics 15, no. 3: 727. https://doi.org/10.3390/pharmaceutics15030727

Núñez, Y., Garcia-León, A., Falgàs, A., Serna, N., Sánchez-García, L., Garrido, A., Sierra, J., Gallardo, A., Unzueta, U., Vázquez, E., Villaverde, A., Mangues, R., & Casanova, I. (2023). T22-PE24-H6 Nanotoxin Selectively Kills CXCR4-High Expressing AML Patient Cells In Vitro and Potently Blocks Dissemination In Vivo. Pharmaceutics, 15(3), 727. https://doi.org/10.3390/pharmaceutics15030727